B. Ettle

发表

Differentiating societal costs of disability worsening in multiple sclerosis

Tjalf Ziemssen, T. Ziemssen, R. Haase, 2019, Journal of Neurology.

Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy

E. Masliah, M. Wegner, J. Winkler, 2019, Brain pathology.

The transitional phase of multiple sclerosis: The concept of PANGAEA 2.0 evolution study.

T. Ziemssen, B. Ettle, Benedict Rauser, 2020, Multiple sclerosis and related disorders.

Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells

E. Masliah, M. Wegner, J. Winkler, 2014, Molecular and Cellular Neuroscience.

α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy

E. Masliah, M. Wegner, J. Winkler, 2014, Neurobiology of Aging.

α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses

J. Winkler, R. Linker, B. Ettle, 2016, Journal of Neuroinflammation.

Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab.

B. Tackenberg, T. Ziemssen, S. Schmidt, 2019, Multiple sclerosis and related disorders.

Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany

T. Ziemssen, K. Gudala, N. Adlard, 2022, Multiple sclerosis journal - experimental, translational and clinical.

Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab

T. Ziemssen, T. Bopp, B. Ettle, 2022, Vaccines.

Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

J. Winkler, J. Schlachetzki, B. Ettle, 2015, Molecular Neurobiology.

Identification of DAPK as a scaffold protein for the LIMK/cofilin complex in TNF-induced apoptosis.

B. Fabry, A. Hartmann, R. Schneider-Stock, 2013, The international journal of biochemistry & cell biology.

Alpha-synuclein activates BV2 microglia dependent on its aggregation state.

J. Winkler, J. Schlachetzki, A. Kulinich, 2016, Biochemical and biophysical research communications.

Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice

E. Masliah, J. Winkler, O. Riess, 2013, Neurobiology of Disease.

Hippocampal structure and function are maintained despite severe innate peripheral inflammation

J. Kornhuber, J. Winkler, G. Schett, 2015, Brain, Behavior, and Immunity.

Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

E. Masliah, R. Barbour, E. Rockenstein, 2013, The American journal of pathology.

α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy

Fred H. Gage, Tobias Bäuerle, Arif B. Ekici, 2016, Acta Neuropathologica.

Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD

E. Masliah, E. Rockenstein, C. Overk, 2014, Acta Neuropathologica.

Serotonergic dysfunction in the A53T alpha‐synuclein mouse model of Parkinson's disease

E. Masliah, J. Winkler, Z. Kohl, 2015, Journal of neurochemistry.

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients

T. Ziemssen, S. Schmidt, Christoph Lassek, 2021, Frontiers in Neurology.

Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis

T. Ziemssen, R. Haase, Nils-Henning Ness, 2020, PharmacoEconomics.

Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

T. Ziemssen, Christoph Lassek, L. Klotz, 2022, Journal of Neurology.

Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis

T. Ziemssen, T. Bopp, B. Ettle, 2023, Vaccines.

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

Raimar Kern, Tjalf Ziemssen, T. Ziemssen, 2020, Journal of medical Internet research.

α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses

J. Winkler, R. Linker, B. Ettle, 2016, Journal of Neuroinflammation.

Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α‐synuclein

J. Winkler, B. Winner, J. Schlachetzki, 2016, Journal of neuroscience research.

Promoting oligodendrocyte progenitor cell maturation and remyelination as a novel therapeutical approach for multiple system atrophy

J. Winkler, J. Schlachetzki, B. Ettle, 2014 .

Patient‐ versus physician‐reported relapses in multiple sclerosis: insights from a large observational study

T. Ziemssen, R. Haase, D. Schriefer, 2020 .

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study (Preprint)

T. Ziemssen, R. Haase, R. Kern, 2020 .

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

T. Ziemssen, R. Haase, R. Kern, 2020, Journal of medical Internet research.